Advertisement
Table 2 Incidence of adverse events per patient
| All Patients (N = 30) | |
|---|---|
| Patients with any treatment-emergent AE, n (%) | 30 (100) |
| Patients with any treatment-emergent serious AE, n (%) | 12 (40) |
| Patients with a grade 3 treatment-related AE, n (%) | 0 |
| Patients with a grade 4 treatment-related AE, n (%) | 0 |
| Patients with a grade 5 treatment-related AE, n (%) | 1 (3) |
| Incidence of treatment-related AEs, n (%) | 18 (60) |
| Fatigue, all grades | 4 (13) |
| Grade 1 | 3 (10) |
| Grade 2 | 1 (3) |
| Infusion-related reaction, all grades | 2 (7) |
| Grade 1 | 2 (7) |
| Pyrexia, all grades | 2 (7) |
| Grade 1 | 2 (7) |
| Decreased appetite, all grades | 2 (7) |
| Grade 1 | 2 (7) |
| Hypophosphataemia, all grades | 2 (7) |
| Grade 2 | 2 (7) |
